Chinese DNA Sequencing Market Report 2018: Workflow, Including Sample Preparation Products, Sequencing Instruments and Consumables, Informatics and Services 2016-2022

Chinese DNA Sequencing Market Report 2018: Workflow, Including Sample Preparation Products, Sequencing Instruments and Consumables, Informatics and Services 2016-2022

DUBLIN, May 23, 2018 /PRNewswire/ --

The "The Chinese Market for DNA Sequencing" report has been added to's offering.

The scope of the report includes sequencing technologies, applications, industries, initiatives, markets and companies in China. The markets for sequencing products and services are given for 2016, 2017 and 2022.

This report covers the Chinese sequencing market by workflow, including sample preparation products, sequencing instruments and consumables, informatics and sequencing services. It includes the Chinese sequencing instrument market by platform (i.e., Sanger and next-generation technologies) and by instrument class (i.e., low-throughput, high-throughput, benchtop, handheld).

More than 100 Chinese companies in the sequencing industry are profiled in this report.


Since the previous edition of this report published in September 2016, the Chinese DNA sequencing market has had many significant developments, including:

    --  Revenues of leading companies maintained fast growth through mid-2018.
        This indicates the high growth rate. The researchers forecast in the
        previous edition of this report that this growth rate was likely to
    --  On October 27, 2016, the Chinese government removed restrictions on NIPT
        services. Any medical body qualified for prenatal examination in China
        is now allowed to do NIPT without additional governmental approval. This
        removed the main obstacle to the Chinese NIPT sequencing market.
    --  The number of newly-established sequencing companies in 2016 and 2017
        was smaller than in 2014 and 2015. New entrants had less opportunity
        while older players led the market.
    --  Companies founded in 2014 and 2015 received funding from angel
        investment and series of A/B rounds. Investors from both inside and
        outside China showed their great interest in the fast-growing Chinese
        DNA sequencing market because the earnings outlook has become clearer
        than before. More than $1 billion was invested in burgeoning Chinese
        sequencing companies in 2017. Some of the older players closed or moved
        to other services. Market opportunity always comes with risks.
    --  Large sequencing service providers are developing their own equipment,
        whereas equipment distributors are beginning to provide sequencing
        services. The upstream and downstream industries interact and intertwine
        with one another.
    --  When NovaSeq launched in early 2017, Novogene decided to buy 25 sets of
        NovaSeq machines. With three sets of HiSeq X Ten and the Novogene
        sequencers, Novogene currently leads the game of instrument investment
        in China. As a result, Novogene strengthens its leading position in the
        sequencing service market, especially in the R&D service market.
    --  Sequencing companies from major cities such as Beijing, Shanghai and
        Shenzhen, where the Chinese DNA sequencing industry begun, are now
        penetrating other Chinese cities. Tianjin, Chengdu and Chongqing have
        shown significant potential for strong growth.
    --  Cooperation, acquisitions and mergers are changing the image of the
        industry, thus increasing competition while producing new opportunities
        to industry players.

Key Topics Covered:

1 Introduction

2 Summary and Highlights

3 Chinese Sequencing Market

4 Guangdong Sequencing Market

5 Beijing Sequencing Market

6 Shanghai Sequencing Market

7 Sequencing Market in Other Regions

8 Industry Structure and Market Strategies

9 Company Profiles

10 Appendix: Glossary

Companies Mentioned

    --  23Mofang
    --  3D Medicines Corporation
    --  Ablife Inc.
    --  Accuragen Inc.
    --  Adicon Clinical Laboratories
    --  Adicon Clinical Laboratories, Inc.
    --  Allwegene
    --  Anchordx
    --  Annoroad Gene Technology
    --  Basecare
    --  Basetra Shanghai
    --  Benagen
    --  Benegene
    --  Berry Genomics Co. Ltd.
    --  BGI
    --  Biogenius
    --  Biological Company Division, Beijing Computing Center
    --  Biomarker
    --  Bionovogene
    --  Bioon
    --  Biorefer
    --  Biosan
    --  Biotecan
    --  Biotechnology Shanghai
    --  Biotree
    --  Boheng
    --  Burning Rock
    --  Capitalbio Technology
    --  Capitalgenomics Co. Ltd.
    --  Cloudhealth Medical Group Ltd.
    --  Cyagen
    --  Cygnus
    --  Daan Gene
    --  Darui Biotechnology Co. Ltd.
    --  Dian Diagnostics
    --  Direct Genomics
    --  Emei Tongde
    --  Ezlife
    --  Find Bio-Tech
    --  Forever Gen
    --  Frasergen
    --  Gemple
    --  Gene Denovo
    --  Genecast
    --  Genedock
    --  Genekang
    --  Geneocean
    --  Genergy Shanghai
    --  Geneseeq
    --  Genesky
    --  Genetron
    --  Genewiz
    --  Gennlife
    --  Gminix
    --  Hangzhou G-Bio Biotech Co. Ltd.
    --  Hangzhou Heyi Gene Technology Co. Ltd.
    --  Hangzhou Lianchuan Bio Technologies Co. Ltd.
    --  Hangzhou Mitian Gene Technology Co. Ltd.
    --  Hangzhou Ptm Biolabs Co. Inc.
    --  Hangzhou Ruichuang Biotechnology Co. Ltd.
    --  Hangzhou Shengting Biotech Co. Ltd.
    --  Hanyu
    --  Haplox
    --  Hikewell
    --  HKGI
    --  Honor Tech
    --  Huaniu Biotechnology
    --  Huasheng Hengye
    --  Huayigenomics
    --  Hyk Gene Technology Co. Ltd.
    --  IGE
    --  Igenetech
    --  IMH Bio
    --  Imuno Biotech Co. Ltd.
    --  IPE
    --  Jabrehoo
    --  Jiayin
    --  Kangchen Bio-Tech
    --  Kindstar
    --  Kingmed Diagnostics Center Co. Ltd.
    --  Linked Biotech
    --  Logic Informatics Co. Ltd.
    --  Lucidus
    --  Macrogen
    --  Magigen
    --  Majorbio
    --  Microbiota
    --  Microhelix Gene
    --  Microread
    --  Mygenostics
    --  New Horizon Health
    --  Nextomics
    --  Novelbio
    --  Novogene Bioinformatics Technology Co. Ltd.
    --  Oebiotech
    --  Offo
    --  Origene China
    --  Paihang
    --  Quanmai
    --  Quanti Health
    --  Qy Node
    --  Reader Bioinformatics
    --  Realgene
    --  Rhonin
    --  Ribobio
    --  Sangon Biotech
    --  Sanvalley
    --  Scisoon
    --  Sensichip
    --  Shanghai Bioasia Gene Co. Ltd.
    --  Shanghai Personal Biotechnology Co. Ltd.
    --  Shanghai Yunying Medical Technology Co. Ltd.
    --  Sinogenomax
    --  Sinomdgene
    --  Sinopath
    --  Solomen Brothers
    --  South Gene
    --  Superbio
    --  Suzshou Biomedical Research And Development Centers
    --  Tgs
    --  Tinygene
    --  Top Gene
    --  Tri-I
    --  Unimed Diagnostic Technology Ltd.
    --  Vishuos
    --  Wuxi Apptec
    --  Xinpeijing
    --  Xybiotech
    --  Yikon Genomics Co. Ltd.
    --  Yingbio
    --  Yucebio Co. Ltd.
    --  Zhejiang Tianke Hi-Technology Development Co. Ltd.
    --  Zi Bio Tech
    --  Zixin Pharmaceutical Industrial Co. Ltd.

For more information about this report visit

Media Contact:

Research and Markets
Laura Wood, Senior Manager

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:

SOURCE Research and Markets